These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Angiogenic factor from metastatic Lewis carcinoma]. Lisniak IA Ukr Biokhim Zh (1978); 1986; 58(6):58-61. PubMed ID: 2432714 [TBL] [Abstract][Full Text] [Related]
23. Inhibitory effect of tumor-bearing state on the generation of in vivo protective immune T cells in a syngeneic murine tumor system. Fujiwara H; Hamaoka T; Nishino Y; Kitagawa M Gan; 1977 Oct; 68(5):589-601. PubMed ID: 73490 [TBL] [Abstract][Full Text] [Related]
24. Angiogenic factor of a rat mammary tumor cell line (RMT-1) (I). Secretion of two distinct angiogenic factors into serum-free conditioned medium by RMT-1 cells. Oikawa T; Hirotani K; Yamaoka K; Katayama T; Iwaguchi T; Ito H; Morita I; Murota S; Tominaga T; Hiragun A Cancer Lett; 1991 Jul; 59(1):57-66. PubMed ID: 1715234 [TBL] [Abstract][Full Text] [Related]
25. Activity of tumor angiogenesis factor obtained from ovarian carcinoma cell line and its purification. Ishiwata I; Ishiwata C; Ishikawa H Nihon Sanka Fujinka Gakkai Zasshi; 1986 Oct; 38(10):1783-4. PubMed ID: 2431081 [No Abstract] [Full Text] [Related]
27. Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2: effect on in vivo mammary tumor growth and angiogenesis. Hajitou A; Sounni NE; Devy L; Grignet-Debrus C; Lewalle JM; Li H; Deroanne CF; Lu H; Colige A; Nusgens BV; Frankenne F; Maron A; Yeh P; Perricaudet M; Chang Y; Soria C; Calberg-Bacq CM; Foidart JM; Noël A Cancer Res; 2001 Apr; 61(8):3450-7. PubMed ID: 11309307 [TBL] [Abstract][Full Text] [Related]
28. Induction of neovascularization by mitogen-activated spleen cells and their supernatants. Pliskin ME; Ginsberg SM; Carp N Transplantation; 1980 Mar; 29(3):255-8. PubMed ID: 6153824 [TBL] [Abstract][Full Text] [Related]
29. Splenic alterations during mammary tumorigenesis: diverse effects on different immune parameters. Paul RD; Ghaffar A; Sigel MM; Charyulu V; Lopez DM Anticancer Res; 1981; 1(2):63-9. PubMed ID: 6214206 [TBL] [Abstract][Full Text] [Related]
30. Immunomodulatory activity of polysaccharide from Helicteres angustifolia L. on 4T1 tumor-bearing mice. Sun S; Li K; Lei Z; Xiao L; Gao R; Zhang Z Biomed Pharmacother; 2018 May; 101():881-888. PubMed ID: 29635897 [TBL] [Abstract][Full Text] [Related]
32. Mechanisms of in vivo generation of cytotoxic effector cells against tumor in tumor-bearing mice. Fuyama S; Yamamoto H; Fujii Y; Arai S Cancer Res; 1986 Nov; 46(11):5548-52. PubMed ID: 2428480 [TBL] [Abstract][Full Text] [Related]
33. Embryonal mass and hormone-associated effects of pregnancy inducing a differential growth of four murine tumors. Bustuoabad OD; di Gianni PD; Franco M; Kordon EC; Vanzulli SI; Meiss RP; Grion LC; Díaz GS; Nosetto SH; Hockl P; Lombardi MG; Pasqualini CD; Ruggiero RA Oncol Res; 2002; 13(3):147-60. PubMed ID: 12549624 [TBL] [Abstract][Full Text] [Related]
34. Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts. Rofstad EK; Halsør EF Cancer Res; 2000 Sep; 60(17):4932-8. PubMed ID: 10987309 [TBL] [Abstract][Full Text] [Related]
35. Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12. Cavallo F; Signorelli P; Giovarelli M; Musiani P; Modesti A; Brunda MJ; Colombo MP; Forni G J Natl Cancer Inst; 1997 Jul; 89(14):1049-58. PubMed ID: 9230887 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses. Sidky YA; Borden EC Cancer Res; 1987 Oct; 47(19):5155-61. PubMed ID: 2441862 [TBL] [Abstract][Full Text] [Related]
37. Muscarinic receptors participation in angiogenic response induced by macrophages from mammary adenocarcinoma-bearing mice. de la Torre E; Davel L; Jasnis MA; Gotoh T; de Lustig ES; Sales ME Breast Cancer Res; 2005; 7(3):R345-52. PubMed ID: 15987429 [TBL] [Abstract][Full Text] [Related]
38. Tumor-conditioned Gr-1(+)CD11b(+) myeloid cells induce angiogenesis through the synergistic action of CCL2 and CXCL16 in vitro. Han EC; Lee J; Ryu SW; Choi C Biochem Biophys Res Commun; 2014 Jan; 443(4):1218-25. PubMed ID: 24388986 [TBL] [Abstract][Full Text] [Related]
39. Effect of plasmacytoma cells on the production of granulocyte-macrophage colony-stimulating activity (GM-CSA) in the spleen of tumor-bearing mice. Merchav S; Apte RN; Tatarsky I; Ber R Exp Hematol; 1987 Oct; 15(9):995-1000. PubMed ID: 3498643 [TBL] [Abstract][Full Text] [Related]
40. Purification and characterization of a novel human angiogenic factor (h-AF). Schulze Osthoff K; Frühbeis B; Overwien B; Hilbig B; Sorg C Biochem Biophys Res Commun; 1987 Aug; 146(3):945-52. PubMed ID: 3619943 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]